About: Sudipta Saha
- Website
- Details
- Associate Professor at Department of Microbiology and Biotechnology, Sister Nivedita University, Kolkata.
Posts by Sudipta Saha:
-
September 11, 2023 Regulatory T cells (Tregs) are important for sperm tolerance and male fertility
-
April 25, 2023 Prediction of exact requirement of exogenous hormone doses in contraceptives to reduce health issues
-
March 1, 2023 Bacterial multidrug resistance problem solved by a broad-spectrum synthetic antibiotic
-
February 14, 2023 Mimicking vaginal cells and microbiome interactions on chip microfluidic culture
-
June 23, 2022 Sperm damage and fertility problem due to COVID-19
-
June 15, 2022 Genomic data can predict miscarriage and IVF failure
-
May 14, 2022 Sperm epigenetic clock and pregnancy outcomes
-
June 17, 2021 Covid-19 and its implications on pregnancy
-
April 8, 2021 Embryogenesis in Mechanical Womb
-
July 16, 2020 Placenta lacks molecules required for COVID-19 infection
Follow Blog via Email
Join 2,041 other subscribers-
Recent Posts
- FDA Moves Forward With Its Guidance Framework for Rare Disease Trials: 2026 August 3, 2026
- Artificial Intelligence TRANSFORMS Medicine, Biotech and Healthcare, How? August 3, 2026
- In Memoriam: Nobel Laureate J. Michael Bishop for discovery of Retroviral Oncogenes July 31, 2026
- Companies Actively Engaging Artificial Intellegence for Drug Design: 2026 July 31, 2026
- AI-Native Drug Discovery Landscape 2026 – How LPBI Group Differentiates in the New Era of Foundation Models July 19, 2026
- In Memoriam: In Remembrance of Cancer Researchers who passed in 2026 July 13, 2026
- Urgent Request for Action on Proposed Rule Affecting Federal Funding Grant Review July 7, 2026
- 2026 Tang Prize in Biopharmaceutical Science Awarded to Three Pioneers of Cellular Immunotherapy Revolutionizing Treatments for Blood Cancers and Solid Tumors July 5, 2026
- Protected: KOL on Competitive Dynamics: LPBI Group’s Founder’s Radar Screens on AI-in-Health, Life Sciences & BioPharma June 15, 2026
- Tumor Infiltrating Lymphocytes (TIL) as a first of kind FDA approved immunotherapy for cancer June 12, 2026
Archives
Categories
Meta